Skip to main content
OpenTrials
Completed

NCT Number: NCT03184285

Continuous Non-invasive Assessment of Blood Pressure in Bariatric Surgery

Comparability of discontinuous non-invasive (sphygomanometric) and continuous semi-invasive and invasive (Masimo© ; Nexfin© Monitoring ; FloTrac© Edwards Lifesciences) beat to beat measurement methods for the determination of arterial blood pressure in patients undergoing bariatric surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Universitätsklinikum Schleswig-Holstein Campus Kiel - Klinik für Anästhesiologie und Operative Intensivmedizin

Kiel, 24105, Germany

About this study

Comparison between non-invasive discontinuous blood pressure measurement using a sphygomanometric blood pressure cuff, and continuous non-invasive and invasive beat to beat blood pressure measurement methods(Nexfin© and FloTrac©).

Bariatric patients show limitations regarding the conventional monitoring options with ECG derivation, pulse oxymetric oxygen saturation and sphygmomanometric blood pressure measurement. From a clinical point of view this results in an invasive arterial blood pressure monitoring . In addition to that, intraoperative extreme changes of the patients position on the table combined with the applied pneumoperitoneum during the minimally invasive laparoscopic surgery can significantly influence the cardiovascular parameters. An invasive arterial blood pressure monitoring is able to reproduce the blood pressure by stroke, but it does not give any information about the cardiac output. The sphygmomanometric blood pressure measurement also entails the risk of insufficient detection of a hypotonic phase in the measurement. Additional monitoring systems are currently available, which are capable of measuring completely non-invasive or semi-invasively different cardiovascular parameters such as cardiac output (CO) and fluid responsiveness. In this study, the investigators will compare continuous and discontinuous cardiovascular monitoring procedures and their parameters. The measurements take place at specific times, under defined changes in the body position with the additional influence of the pneumoperitoneum.

These changes are recorded and compared at the same time during different measuring methods preoperatively, intraoperatively and postoperatively. The non-invasive Nexfin© Monitoring (Edwards Lifesciences) is to be evaluated and compared with further measurement methods (FloTrac© (Edwards Lifesciences)) as well as the sphygmomanometric upper arm blood pressure measurement. The investigators also compare the non-invasive and invasive continuous beat to beat blood pressure measurement with conventional, discontinuous sphygomanometric upper arm blood pressure measurement.

The planned study is the comparison of 3 different hemodynamic monitoring procedures. For the evaluation the investigators use the method described by Bland and Altmann for calculating the mean deviation (bias) and the precision (mean value ± 2 standard deviations. In the case of multiple measurements , the modification of the Bland-Altman method is applied (repeated measurements). The number of cases was determined with n = 60 patients, followed by an intermediate evaluation. For a Bland-Altman analysis, the width w of the confidence interval for the Limits of Agreement is calculated as w = 6.79 • σ • 1 / √n, where n is number of cases and σ is the standard deviation. For a case count of n = 60, the result is w = 0.88 • σ and thus for this explorative study a sufficiently large number. In case of the dynamic variables, the percentage matching and the calculation of the kappa index are also used for the statistical evaluation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Indication for bariatric surgery was made
  • Classification according to the American Society of Anesthesiologists (ASA) 2-4
  • Age > 18 years
  • Elective laparoscopic surgery
  • Written declaration of consent
  • Body Mass Index > 30 kg / m²

Exclusion criteria

  • atrial fibrillation
  • cardiac arrhythmias
  • aortic aneurysm > 4,5 cm
  • Peripheral arterial occlusive desease grade 3-4
  • age < 18 years
  • missing or incorrect patient consent form
  • cognitive or linguistic barriers

Treatment and study plan

baseline alert 1

Procedure

measurement in supine position

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

Anti-Trendelenburg-position (ATB)

Procedure

measurement under ATB

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

ATB in narcosis

Procedure

measurement under ATB in narcosis

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

baseline in narcosis 1

Procedure

measurement in supine position in narcosis

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

passive leg raising

Procedure

measurement under passive leg raising

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

volume bolus substitution

Procedure

measurement in supine position after volume bolus (15 ml/kgKG Sterofundin balanced solution intravenous)

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

baseline in narcosis 2

Procedure

measurement in supine position

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

start capnoperitoneum

Procedure

measurement in supine position

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

ATB plus capnoperitoneum

Procedure

measurement under ATB plus capnoperitoneum

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

ATB plus capnoperitoneum plus volume bolus substitution

Procedure

measurement in ATB plus capnoperitoneum after volume bolus (15 ml/kgKG Sterofundin balanced solution intravenous)

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

ATB loss of capnoperitoneum

Procedure

measurement under ATB

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

baseline

Procedure

measurement in supine position

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

baseline alert 2

Procedure

measurement in supine position

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

torso position rising 30° at the beginning

Procedure

measurement in the recovery unit

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

torso position rising 30° at the end

Procedure

measurement in the recovery unit

Other names: Device, Nexfin© vs FloTrac© vs sphygmomanometric blood pressure

Primary outcomes

  1. Non-invasive arterial blood pressure measurement in comparison to invasive measurement in bariatric surgery

    Time frame: From the beginning of surgery to admission to the PACU, approximately 4 hours

    Accuracy of non-invasive beat-to-beat blood pressure measurement and sphygmomanometric measure in comparison to the invasive Gold standard.

Sponsors and collaborators

Lead sponsor

University Hospital Schleswig-Holstein

Other

Registry information

Official study title

Continuous Non-invasive Assessment of Blood Pressure in Comparison to the Invasive Gold-standard and to the Sphygmomanometer.

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Jun 12, 2017
Registry last updated
Jun 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.